Antifungal Drugs I. Humans and fungi share a common biosynthetic pathway for sterols from squalene (via squalene 2,3 epoxidase and other enzymes) to lanosterol.

Slides:



Advertisements
Similar presentations
Antifungal Drugs Infectious diseases caused by fungi are called mycoses, and they are often chronic in nature. Fungal infectious occur due to : 1- Abuse.
Advertisements

FUNGAL INFECTIONS Traditionally have been divided into two distinct classes: systemic and superficial.
Anti-fungal agents Fungal infections to a large extent are iatrogenic in nature. Fungal infections are associated with the use of broad spectrum antibiotic,
Antifungal drugs Assoc. Prof. Ivan Lambev
Antifungal drugs By S.Bohlooli, PhD
Fungi Plant-like organisms that lack chlorophyll 1 of the 5 Kingdoms
Antifungal Agents Fen-Fei Gao.
Chapter 91 Antifungal Agents 1.
Antifungal Drugs.
Before and after slides: -Less text and bullets-more pictures -Make pictures the center and not the text -Use nice large high-definition pictures -No more.
ANTIFUNGAL DRUGS.
ANTIFUNGAL DRUGS Fungal infections (mycoses) can be both superficial and systemic. Superficial infections (Oral and vulvovaginal candidiasis, Dermatophytosis,
Antifungal agents Mycotic Infections: Cutaneous Subcutaneous
Sulfonamides and Antimicrobial Antifolates
Fungal Basics and Antifungals Slackers Facts by Mike Ori.
Pharmacology-4 PHL 425 Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Quick Anti-fungals By Sarah E.. Anti-fungals Name the 6 categories of anti-fungals 1.Polyenes 2.-azoles 3.Synthetic allylamines 4.Anti-metabolites 5.Echinocandins.
ANTIFUNGAL AGENTS subhash k. mohan UHN – TML & Mount Sinai Hospital.
Antifungal Drugs Fungal infectious occur due to :
Combination Antifungal Therapy By Amy Barnett, Doctor of Pharmacy Candidate University of Florida College of Pharmacy.
Recommended text books
Antifungal Drugs.
Antifungal Agents Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan.
Flucoral capsules Product knowledge. Pharmacokinetics of fluconazole Distribution of Fluconazole is extensive and even throughout tissues. The high polarity.
PHPR 202: ANTIFUNGAL THERAPY Andrew Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University School of Pharmacy.
Anti-Fungal Compounds Eukaryotic pathogens –Similar cell structure and function Many fungi are opportunistic –Fungal infections on the rise Most have detoxification.
CHAPTER 10-3 Dr. Dipa Brahmbhatt VMD MpH
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 41 Antifungal Drugs.
Antifungal Agents Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan.
Diagnosis 1. Wet Mount 2. Skin test 3. Serology 4. Fluorescent antibody 5. Biopsy and histopathology 6. Culture 7. DNA probes.
Pharmacology-4 PHL 425 Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Antifungal Agents.
ANTIFUNGAL DRUGS Modes of Action Mechanisms of Resistance
Diversity of Fungi and Fungal Infections
By Dr.Mohamed Abd AlMoneim Attia
Case No. 10 Chen, I- Ling( Claire). GTZ, 57 y/o female, came in because of vaginal pruitus. She also experience weight loss, polyphagia, polyuria, nocturia.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Antifungal Chemotherapy Fungal infections are termed mycoses and can be divided into: (1) Superficial infections: affecting skin, nails, scalp or mucous.
Antifungal agents. Superficial mycoses Cutaneous mycoses Subcutaneous mycoses Systemic or deep mycoses Affects hair and skin epidermis e.g. tinea versicolor,
Antifungal Drugs Fungal infectious occur due to : 1- Abuse of broad spectrum antibiotics 2- Decrease in the patient immunity e.g DM, corticosteroid therapy,
Systemic & Topical Some are fungistatic, while others are fungicidal.
ANTIFUNGAL DRUGS PHARM 514 Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington
5. Antifungal Agents Pharmacognosy IV PHG 423 Dr/ Abdulaziz Saeedan Pharmacy College 1.
Antifungal Agents Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan.
University of Karbala College of veterinary medicine Second semester Pharmacology Lect. # 2 Antifungal Drugs Dr. Sattar K. Abdul-Hussain, Ph.D, DVM, DABT.
ANTIFUNGAL DRUGS.
By Dr.Mohamed Abd AlMoneim Attia
Antifungal drugs Lec Dr. Naza M. Ali
Antifungal Drugs.
Antifungal drugs.
Brielle Haas RISE Spring 2015 Dr. Gullo
Department of Pharmacology
Sites of action of antifungal drugs
Diversity of Fungi and Fungal Infections
ANTIFUNGALS Fungus single cell organism with cell wall has chitin, no chlorophyhll. reproduction by spores. study is mycology most are resistant.
Antifungal drugs Lec Dr. Naza M. Ali
Antifungal Agents Chapter 11.
Copyright © 2017, Elsevier Inc. All rights reserved.
Anti-fungal agents Problem: Fungi are eukaryotes
Mycology.
Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature.
Antifungal agents.
Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature.
School of Pharmacy, University of Nizwa
Antifungals 20 November :58 AM.
School of Pharmacy, University of Nizwa
Antifungal Agents “Antifungal agents are the drugs used against fungal infection and can be either fungistatic or fungicidal.”
Lecturer name: Dr. Ahmed M. Albarrag
AL-Mustansiriyah university college of pharmacy
Presentation transcript:

Antifungal Drugs I

Humans and fungi share a common biosynthetic pathway for sterols from squalene (via squalene 2,3 epoxidase and other enzymes) to lanosterol (via 14-alpha-demethylase and other enzymes) to zymosterol. After that, humans go down a cholesterol synthesis pathway, and fungi down an ergosterol synthesis pathway.

Amphotericin B is an amphoteric molecule. It binds to sterols (ergosterol) in fungi cell membranes, and in this hydrophobic environment it forms a pore with the hydrophobic side out and the hydrophilic side in.

This allows small molecules to leak and the fungal cell to burst. Amphotericin B binds more avidly to ergosterol (more hydrophobic) than cholesterol, but the selectivity isn’t great.

Amphotericin is given IV for potentially fatal fungal infections like invasive aspergillosis or disseminated candidiasis. It has many side effects like nephrotoxicity, fever/chills, and hypotension (shake n bake) Later lipid formulations are equally efficacious but with less toxicity. They are more expensive, though.

Nystatin works by an almost identical mechanism. It is a topical preparation and treats oral, vaginal or cutaneous candidiasis. Azoles inhibit 14-alpha-demethylase, part of the shared sterol biosynthetic pathways of humans and fungi.

This results in less ergosterol, more membrane permeability and leakage of small molecules. Side effects include GI distress, rash, severe hepatotoxicity (not common), and because it its target, 14-alpha- demethylase, is a cytP450 enzyme, it can have drug interactions.

Ketoconazole – Only oral, with a 12 hour half life. It’s degraded in liver and excreted in urine. It’s a good alternative to amphotericin B for systemic and mucocutaneous fungal infections, because it has less toxicity.

Fluconazole – Good oral absorption, independent of gastric acidity. It penetrates well into the CSF and eye. Most elimination is renal in an unmetabolized form. The half-life is hours. It’s fungistatic, and is used to prevent progression of Cryptococcal meningitis or to prevent candida infections (as in transplant patients).

Itraconizole – erratic oral absorption improved by food or acid (so may be given IV). It’s metabolized hepatically and inactive metabolites are excreted in urine and bile. It has a half life of hours. It’s used for systemic fungal infections with fewer side effects than ketoconazole.

Vorconazole – 85% bioavailable, improved by an empty stomach. It’s metabolized hepatically and inactive metabolites are excreted in the urine and bile. Used for invasive aspergillosis and candida.

Allylamines inhibit ergosterol biosynthesis and also increase membrane permeability and leakage. Allylamines inhibit squalene 2,3 epoxidase very potently, with a 2000x selectivity for the fungal enzyme over the human analog. So, they don’t really affect cholesterol synthesis much.

o Naftifine – topical o Terbinafine – oral or topical

Flucytosine (5FC) gets converted to 5-flurouracil (5FU), which can be modified and incorporated into mRNA to interfere with fungal protein synthesis, or can be modified to inhibit thymidylate synthesis (inhibiting pyrimidine production and therefore DNA synthesis).

Our enzymes can’t convert it to the active 5FU form, so it’s not too toxic for us. The GI flora may do this and lead to the presence of 5FU in us, which can cause some side effects.

Resistance develops rapidly, so it can’t be used as a monotherapy. It’s given with amphotericin B for systemic candida and Cryptococcus infections. Generally, it’s well tolerated, but it can cause bone marrow depression, GI distress or reversible hepatotoxicity. This may arise from the GI flora converting it to the active 5FU.

Griseofulvin is actively transported into fungal cells where it disrupts microtubules and leads to cell cycle arrest at mitosis and the formation of multinucleated cells. Mammals lack the active transport system for this drug. It’s used for severe infections of the hair, nails, palm and soles where it accumulates in us

Griseofulvin may produce GI distress or headache, but even these side effects are well tolerated. It’s absorbed very well and is distributed to the skin, hair and nails.

Cell-wall synthesis inhibitors: Caspofungan, micafungin, anidulafungin. These irreversibly inhibit 1,3- beta-D-glucan synthase, a key step in cell wall biosynthesis. It is fungicidal, and its unique mechanism means no cross- resistance with other classes. It’s used for aspergillus, and also for candida

Caspofungan is used for salvage therapy in cases of invasive aspergillosis, for esophageal candidiasis or candidemia. Micafungin is used for prophylaxis of candidiasis in bone- marrow transplant recipients and treatment of esophageal candidiasis. Anidulafungin is used to treat candidemia.

Toxicity occurs in ~14% of patients, and it manifests as fever, nausea, vomiting, and complains at the site of infusion.